Sera Prognostics (SERA) Long-Term Debt Repayments (2020 - 2021)
Sera Prognostics posted quarterly Long-Term Debt Repayments of $1.4 million for Q4 2021, up 2150.0% year-on-year from $61955.6 in Q4 2020, and up 200.0% on a QoQ basis from -$1.4 million in Q2 2021.
Sera Prognostics (SERA) has 2 years of Long-Term Debt Repayments data on file, last reported at $1.4 million in Q4 2021.
- For the quarter ending Q4 2021, Long-Term Debt Repayments rose 2150.0% year-over-year to $1.4 million; the trailing twelve-month figure through Sep 2022 stood at $1.4 million (up 159.11% YoY), and the FY2021 full-year result was $4.5 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q4 2021 stood at $1.4 million, up from -$1.4 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $2.0 million in Q1 2021 and bottomed at -$1.4 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.39 Mn |
| Dec 31, 2021 | 1.39 Mn |
| Jun 30, 2021 | -1.39 Mn |
| Jun 30, 2021 | -1.39 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Dec 31, 2020 | -68,000.00 |
| Dec 31, 2020 | -68,000.00 |
| Sep 30, 2020 | 68,000.00 |
| Sep 30, 2020 | 68,000.00 |